PMID: 8468765Apr 28, 1993Paper

Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial

JAMA : the Journal of the American Medical Association
G A ChrousosP A Cleary

Abstract

To determine the incidence of side effects from short-term glucocorticoid therapy prescribed for treatment of optic neuritis in the Optic Neuritis Treatment Trial. Randomized, placebo-controlled, multicenter clinical trial. Fifteen university- or hospital-based centers throughout the United States. A total of 457 patients between the ages of 18 and 46 years with acute demyelinative optic neuritis were studied. (1) Intravenous methylprednisolone (250 mg every 6 hours) for 3 days while hospitalized followed by oral prednisone (1 mg/kg per day) for 11 days; (2) oral prednisone (1 mg/kg per day) for 14 days; and (3) oral placebo for 14 days. Each regimen was followed by a short taper. Only two patients experienced major side effects, psychotic depression in one and acute pancreatitis in the other. Both of these patients were from the intravenous methylprednisolone group and both of the side effects resolved without sequelae. Patients in both groups receiving active drugs more often reported sleep disturbances, mood change, stomach upset, and facial flushing and gained more weight during the treatment period than patients in the placebo group (P < .001 for each comparison). Although minor side effects are common, short-term glucocor...Continue Reading

Citations

Apr 26, 2002·The British Journal of Ophthalmology·E TokerN Acar
Nov 19, 2008·Journal of Medical Case Reports·Deepthi Renuka SeneviratneTheresa Worstmann
Apr 30, 2011·Eye·D PauA G Lee
Nov 30, 2000·Current Treatment Options in Neurology·D I Kaufman
Jun 8, 2001·Current Treatment Options in Neurology·Laura J. Balcer
Apr 9, 2005·Current Treatment Options in Neurology·Dean M Wingerchuk, Brian G Weinshenker
Mar 8, 2008·Current Treatment Options in Neurology·Dean M Wingerchuk, Brian G Weinshenker
Apr 16, 2010·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·A BrüggemannM Müller
Aug 10, 2000·Clinical & Experimental Ophthalmology·D WakefieldP J McCluskey
Feb 24, 2001·Clinical & Experimental Ophthalmology·M A ThielD J Coster
Mar 2, 2006·Ocular Immunology and Inflammation·Nikos N MarkomichelakisTasos Kouris
Jan 29, 2016·The Journal of Pharmacy and Pharmacology·Eroneide S B CardosoSara M Thomazzi
May 20, 2003·The Kaohsiung Journal of Medical Sciences·Youn-Shen BeeShwu-Jiuan Sheu
Mar 11, 2009·The Medical Clinics of North America·Ardith M CourtneyElliot Frohman
Oct 7, 2005·International Journal of Dermatology·Vikram K MahajanGeeta Garg
Jun 6, 2003·Clinical & Experimental Ophthalmology·Colin C K Chan, Justin O'Day
May 8, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J S PerumalO Khan
Dec 6, 2005·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·F SellebjergUNKNOWN EFNS Task Force on Treatment of Multiple Sclerosis Relapses
Oct 22, 2008·Acta Ophthalmologica·Aki Kawasaki, Valerie Purvin
Mar 27, 2013·The FEBS Journal·Andrew MarianoRenzhi Han
Feb 22, 2012·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Emily M FredericksM James Lopez
Jul 6, 2010·Dermatologic Therapy·Richelle M KnudsonAlison J Bruce
Mar 25, 1998·American Journal of Ophthalmology·J B ReedI R Schwab
Jul 30, 2014·Pediatric Blood & Cancer·Valerie E RogersPamela S Hinds
Mar 28, 1998·Neurologic Clinics·H Machkhas, Y Harati
Dec 23, 2008·American Journal of Ophthalmology·Frederick L Ferris
Sep 1, 1995·Seminars in Ophthalmology·B KatzR W Beck
Apr 18, 2009·Respiratory Medicine·Stephanie C MansonCarlos Fernandez Vidaurre
Nov 13, 2015·Practical Neurology·Emma C TallantyreNeil P Robertson
Jul 3, 2018·Asia-Pacific Journal of Ophthalmology·Leanne Stunkel, Gregory P Van Stavern
Nov 1, 2013·Clinical Pharmacology and Therapeutics·O H KantarciM Rodriguez
Oct 19, 2019·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·O D OstroumovaA P Pereverzev

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.